Blue Owl Capital Inc completes a deal to acquire a portfolio of private hospitals in the United Kingdom valued at £1.3 billion, according to reports. The seller is Malaysia’s Employees Provident Fund (EPF). The transaction involves Blue Owl taking ownership of the UK hospital portfolio previously held by EPF. The reports state the purchase price and describe the overall agreement as a portfolio acquisition rather than a single-facility sale. With the acquisition completed, the portfolio becomes part of Blue Owl’s investments. The available information does not specify which hospitals are included, the precise structure of the transaction, or any changes to ownership and operations following completion. No further financial terms beyond the reported £1.3 billion consideration are provided in the cited summaries. Overall, both sources align on the deal size, the buyer, and the seller, indicating that Blue Owl is expanding its healthcare-related investment exposure in the UK through this completed portfolio purchase.
Blue Owl completes £1.3 billion UK private hospital portfolio purchase
Blue Owl Capital Inc completes a deal to acquire a portfolio of private hospitals in the United Kingdom valued at £1.3 billion, according to reports. The seller is Malaysia’s Employees Provident Fund...
- Blue Owl Capital Inc completes a purchase of a UK private hospital portfolio valued at £1.3 billion.
- The seller is Malaysia’s Employees Provident Fund (EPF).
- The transaction is described as a portfolio acquisition of multiple UK hospitals.
- The reports indicate the deal has been completed, not announced or pending.
- No additional deal terms or hospital-by-hospital details are provided in the cited summaries.
Blue Owl Capital Inc has completed a deal to buy a portfolio of UK private hospitals from Malaysia’s Employees Provident Fund.
6 hours ago
AP POLYCET 2026 Round 1 seat allotment result released online
The AP POLYCET 2026 Round 1 seat allotment result is released online by Andhra Pradesh’s technical education authorities...
Kalohexis confidentially files for U.S. IPO for obesity and cachexia pipeline
Kalohexis, a clinical-stage biopharmaceutical company focused on treatments for obesity and cachexia, has confidentially...
Kangana Ranaut comments on Siya Goyal–Chetan Chaudhary marriage claims in Ketan Agarwal murder case
Actress and BJP MP Kangana Ranaut reacts to reports alleging that murder accused Siya Goyal and her alleged lover Chetan...